Li B, Yang W, Liu N, Bi D, et al. Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study. Br J Cancer 2024 Oct 24. doi: 10.1038/s41416-024-02885.
PMID: 39448860